Risk factors for post-ICU red blood cell transfusion: a prospective study.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 1751083)

Published in Crit Care on January 01, 2006

Authors

Sophie Marque1, Alain Cariou, Jean-Daniel Chiche, Vincent Olivier Mallet, Frédéric Pene, Jean-Paul Mira, Jean-François Dhainaut, Yann-Erick Claessens

Author Affiliations

1: Medical Intensive Care Unit, Cochin Hospital, rue du Faubourg Saint-Jacques, F-75679 Paris Cedex 14, France.

Articles cited by this

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

Anemia and blood transfusion in critically ill patients. JAMA (2002) 7.83

Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43

The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA (1996) 4.30

Transfusion medicine. First of two parts--blood transfusion. N Engl J Med (1999) 4.21

Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA (2002) 4.09

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65

Consensus conference. Perioperative red blood cell transfusion. JAMA (1988) 2.44

Iron, infections, and anemia of inflammation. Clin Infect Dis (1997) 2.27

RBC transfusion in the ICU. Is there a reason? Chest (1995) 1.60

A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med (1998) 1.58

Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med (1997) 1.34

Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med (1999) 1.32

Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med (2003) 1.10

Erythropoiesis abnormalities contribute to early-onset anemia in patients with septic shock. Am J Respir Crit Care Med (2006) 0.83

Articles by these authors

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med (2015) 10.15

Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19

High versus low blood-pressure target in patients with septic shock. N Engl J Med (2014) 7.37

Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med (2015) 7.02

Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet (2006) 6.49

Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med (2008) 4.21

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18

Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation (2002) 3.16

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med (2009) 3.07

Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA (2013) 2.97

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96

Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv (2010) 2.91

Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med (2015) 2.81

Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Resuscitation (2014) 2.76

Short- and long-term outcome in elderly patients after out-of-hospital cardiac arrest: a cohort study. Crit Care Med (2014) 2.70

Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA (2008) 2.61

Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med (2008) 2.56

Influence of overweight on ICU mortality: a prospective study. Chest (2004) 2.54

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Crit Care Med (2012) 2.51

Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J (2006) 2.30

Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol (2002) 2.27

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25

Important questions asked by family members of intensive care unit patients. Crit Care Med (2011) 2.22

Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC). Intensive Care Med (2014) 2.16

Benefit of an early and systematic imaging procedure after cardiac arrest: insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) registry. Resuscitation (2012) 2.13

Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med (2004) 2.05

Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02

Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med (2002) 1.97

Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care (2004) 1.93

Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med (2008) 1.89

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Oncogene (2002) 1.87

Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One (2010) 1.86

Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Crit Care Med (2002) 1.81

Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med (2013) 1.81

Combining high-frequency oscillatory ventilation and recruitment maneuvers in adults with early acute respiratory distress syndrome: the Treatment with Oscillation and an Open Lung Strategy (TOOLS) Trial pilot study. Crit Care Med (2005) 1.81

Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med (2009) 1.76

Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med (2005) 1.71

High frequency oscillatory ventilation compared with conventional mechanical ventilation in adult respiratory distress syndrome: a randomized controlled trial [ISRCTN24242669]. Crit Care (2005) 1.69

Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era. Crit Care Med (2011) 1.68

IRAK1 functional genetic variant affects severity of septic shock. Crit Care Med (2010) 1.64

Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation (2011) 1.63

Out-of-hospital cardiac arrest from brain cause: epidemiology, clinical features, and outcome in a multicenter cohort*. Crit Care Med (2015) 1.62

Long-term prognosis following resuscitation from out of hospital cardiac arrest: role of percutaneous coronary intervention and therapeutic hypothermia. J Am Coll Cardiol (2012) 1.62

Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med (2011) 1.62

Biological evaluation of perioperative cardiac stress: a two-way approach. Crit Care Med (2006) 1.60

Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59

Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med (2012) 1.58

Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis (2003) 1.58

The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis (2005) 1.57

Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med (2007) 1.57

Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study. PLoS One (2012) 1.56

Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. Crit Care Med (2014) 1.56

High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol (2005) 1.56

Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med (2004) 1.56

Blood glucose level and outcome after cardiac arrest: insights from a large registry in the hypothermia era. Intensive Care Med (2014) 1.51

Experts' recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care (2015) 1.51

Testing protocols in the intensive care unit: complex trials of complex interventions for complex patients. JAMA (2008) 1.51

Ability of family members to predict patient's consent to critical care research. Intensive Care Med (2007) 1.50

Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med (2011) 1.47

Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoring. Crit Care (2009) 1.46

Reference range values of troponin measured by sensitive assays in elderly patients without any cardiac signs/symptoms. Clin Chim Acta (2012) 1.44

Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.43

Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway. J Am Coll Cardiol (2005) 1.43

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood (2002) 1.43